Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micro- and nano-plastics in the coronary circulation and air pollution exposure in ischaemic heart disease presentation.

European heart journal·2026
Same author

Clinical and haemodynamic outcomes with contemporary intra- and supra-annular self-expanding valves: the multicentre international HERA-TAVI registry.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Evolving Indications for Transcatheter Aortic Valve Implantation: Key Issues From Procedural Challenges to Lifetime Management.

The Canadian journal of cardiology·2025
Same author

Strategies for a patient with severe aortic stenosis affected by appendage thrombosis, atrial fibrillation and coronary artery disease to undergo TAVI.

Journal of geriatric cardiology : JGC·2025
Same author

Management of Coronary Vulnerable Plaques: A Focus on Preventive Percutaneous Coronary Intervention.

Reviews in cardiovascular medicine·2025
Same author

Predictors of permanent pacemaker implantation after TAVI with Navitor transcatheter heart valve.

Cardiovascular revascularization medicine : including molecular interventions·2025

Related Experiment Video

Updated: Jul 10, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.6K

Future of left atrial appendage interventions.

Matteo Casenghi1, Sara Corradetti2, Emiliano Navarra2

  • 1Sant'Andrea Hospital, Rome, Italy - matcasenghi@hotmail.it.

Minerva Cardiology and Angiology
|June 6, 2024
PubMed
Summary

Percutaneous left atrial appendage occlusion (LAAO) is a low-risk procedure for preventing stroke in atrial fibrillation patients. Further research is needed to optimize safety, efficacy, and standardization for wider adoption.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K
Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
04:37

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications

Published on: June 16, 2023

1.1K

Related Experiment Videos

Last Updated: Jul 10, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.6K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K
Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
04:37

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications

Published on: June 16, 2023

1.1K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Percutaneous left atrial appendage occlusion (LAAO) is an emerging procedure for stroke prevention in patients with atrial fibrillation.
  • While recognized as relatively low-risk, LAAO requires further optimization to compete with newer oral anticoagulants.
  • Challenges include comprehensive data acquisition, standardized planning, and procedural simplification.

Purpose of the Study:

  • To provide an overview of future opportunities for enhancing LAAO safety and efficacy.
  • To establish LAAO as a mainstream strategy for stroke and systemic embolism prevention.
  • To address patients with atrial fibrillation and contraindications to anticoagulant drugs.

Main Methods:

  • Review of current clinical practices and challenges in LAAO.
  • Analysis of existing data on safety and efficacy.
  • Discussion of potential strategies for procedural optimization and standardization.

Main Results:

  • LAAO is a viable, low-risk alternative for stroke prevention in specific patient populations.
  • Opportunities exist to improve data collection, pre-procedural planning, and procedural techniques.
  • Standardization and further evidence generation are key to establishing LAAO as a mainstream therapy.

Conclusions:

  • Enhancing procedural safety and efficacy through data acquisition and standardization is crucial for LAAO.
  • LAAO holds significant potential as a primary stroke prevention strategy for patients with atrial fibrillation and contraindications to anticoagulation.
  • Continued research and development are necessary to fully realize the benefits of LAAO.